Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Recent & Breaking News (NDAQ:SAVA)

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - (SAVA)

Newsfile September 23, 2021

ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA

PR Newswire September 23, 2021

Cassava Class Action Reminder

Newsfile September 23, 2021

SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.

Newsfile September 23, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences (SAVA) Investors with Losses in Excess of $250,000 to Contact Firm's Attorneys Now, Securities Fraud Class Action Filed

Newsfile September 23, 2021

SAVA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 26, 2021 in the Class Action Filed on Behalf of Cassava Sciences, Inc. Limited Shareholders

Newsfile September 23, 2021

SAVA INVESTOR LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc.

PR Newswire September 23, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA

Newsfile September 23, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AHCO, ITRM and SAVA

Accesswire September 23, 2021

Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Cassava Sciences, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

Newsfile September 22, 2021

Cassava Shareholder Notice

Newsfile September 22, 2021

SAVA: Berman Tabacco Alerts Investors with Losses Over $200,000 in Cassava Sciences, Inc. of Approaching Lead Plaintiff Deadline

Newsfile September 22, 2021

Cassava Sciences Announces Top-line Results of 12-month Interim Analysis from Open-label Study Evaluating Simufilam in Alzheimer's Disease

GlobeNewswire September 22, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PHG, ANVS and SAVA

Accesswire September 22, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA

Newsfile September 21, 2021

Cassava Shareholder Alert

Newsfile September 21, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA

Newsfile September 21, 2021

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA

Newsfile September 21, 2021

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Cassava Sciences, Inc. (SAVA) Investors and Encourages Investors to Contact the Firm Before October 26, 2021

Business Wire September 21, 2021

Cassava Sciences News: Berger Montague Investigates Securities Fraud Allegations Against Cassava Sciences Inc. (SAVA); Lead Plaintiff Deadline is October 26, 2021

Newsfile September 21, 2021